








































The anesthetic goals in flap surgery are to provide 
optimal tissue perfusion and oxygenation.1 Intraoperative 
hypotension is a well-known risk for postoperative com-
plications and is commonly counteracted by intravenous 
crystalloid infusion.2,3 Intravenous colloids can provide 
additional support to prevent hypotension.4 Besides nor-
mal insensible water loss and urine production, there is a 
constant physiological fluid transfer from the intravascu-
lar to the interstitial compartment.5 Ischemia-reperfusion 
injury (IRI) can induce increased capillary leakage, 
leading to excessive fluid entrapment in the tissue.6 
Superfluous intraoperative fluid resuscitation causes 
interstitial fluid overload and results in an increased risk 
for complications.4,7,8
Vasopressors can be used to maintain adequate blood 
pressure and reduce the need for additional fluid infu-
sion. In reconstructive microsurgery, there has been skep-
ticism toward using vasoactive agents due to concern of 
vasospasm and reduced flap perfusion.9
Inspired by studies on restrictive fluid administration 
in elective gastrointestinal surgery, we introduced in 2005 
a modified fluid management (MFM) protocol in abdom-
inal-flap breast reconstructions, aiming to reduce intra-
operative fluid volumes and complications.10 Vasopressors 
were used liberally to maintain normotension, and 
propofol (Propofol-Lipuro, B. Braun, Melsungen AG, 
Germany) was introduced to minimize the impact of 
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Abstract
Background: The outcome of reconstructive microsurgery is influenced by the 
intraoperative anesthetic regimen. The aim of this study was to compare the impact 
on the intra- and postoperative complication rates of our modified fluid manage-
ment (MFM) protocol with a previously used liberal fluid management protocol in 
abdominal-flap breast reconstructions.
Methods: This retrospective study analyzed adverse events related to secondary 
unilateral abdominal-flap breast reconstructions in two patient cohorts, one with a 
liberal fluid management protocol and one with a MFM protocol. In the MFM pro-
tocol, intravenous fluid resuscitation was restricted and colloid use was minimized. 
Both noradrenaline and propofol were implemented as standard in the MFM pro-
tocol. The primary endpoints were surgical and medical complications, as observed 
intraoperatively or postoperatively, during or shortly after the hospital stay.
Results: Of the 214 patients included in the study, 172 patients followed the MFM 
protocol. Prior radiotherapy was more frequent in the MFM protocol. Surgical pro-
cedures to achieve venous superdrainage were more often used in the MFM cohort. 
Intraoperative as well as postoperative complications occurred significantly more 
frequently in the liberal fluid management cohort and were specifically associated 
with partial and total flap failures. Prior radiotherapy, additional venous drainage, 
or choice of inhalation agent did not have an observable impact on outcome.
Conclusions: The incidence of adverse events during and after autologous breast 
reconstructive procedures was reduced with the introduction of an MFM proto-
col. Strict intraoperative fluid control combined with norepinephrine and pro-
pofol was both beneficial and safe. (Plast Reconstr Surg Glob Open 2021;9:e3830; doi: 
10.1097/GOX.0000000000003830; Published online 17 September 2021.)
Liberal versus Modified Intraoperative Fluid 
Management in Abdominal-flap Breast 
Reconstructions. A Clinical Study
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IRI.11 The aim of this study was to compare the impact 
of our MFM protocol with a previously used liberal fluid 
management (LFM) protocol on intra- and postopera-
tive complications in secondary unilateral abdominal-flap 
breast reconstructions.
PATIENTS
This retrospective study included patients scheduled 
for secondary unilateral abdominal-flap breast recon-
struction over a period of 20 years (1999–2018). The 
study was approved by the regional ethical committee and 
accomplished in accordance with the Helsinki declara-
tion. Patients were allocated to two cohorts, correspond-
ing to which of the two protocols was followed. The MFM 
protocol was fully implemented in 2005, which therefore 
served as a dividing time-point between cohorts. Exclusion 
criteria were patients with obstructive pulmonary disease, 
coronary artery disease, peripheral arterial disease, or use 
of nicotine products within three months before admis-
sion. A complete anesthesia record was mandatory.
METHODS
The Liberal Fluid Management Protocol
The LFM comprised isoflurane or sevoflurane inhala-
tion anesthesia at the discretion of the anesthesiologist. 
Crystalloids were used to maintain normotension (mean 
arterial pressure ≥ 65 mm Hg). Intravenous colloids were 
added on demand to correct hypotension irresponsive 
to increased crystalloid fluid infusion. Vasopressors were 
occasionally utilized to correct hypotension, unless man-
ageable with intravenous fluids and colloids.
The Modified Fluid Management Protocol
The MFM comprised sevoflurane as the predominant 
inhalation anesthetic. Crystalloids combined with vasoac-
tive agents were used to maintain mean arterial pressure of 
65 mm Hg or greater. Colloids were used very restrictively 
and only to correct hypotension irresponsive to boluses 
of norepinephrine and crystalloids. Inhalation anesthesia 
was replaced by propofol infusion after completion of the 
microvascular anastomoses.
Surgical Treatment and Follow-up
Pedicled transverse rectus abdominis musculocutane-
ous flaps were performed by a single team, whereas free 
flap surgery was accomplished by a two-team approach 
using the internal mammary vessels as the preferred 
recipient vessels. Venous superdrainage was performed if 
venous congestion was suspected, based on intraoperative 
assessment by infrared thermography and clinical signs.
Hemoglobin and hematocrit levels were measured pre-
operatively and 1 and 2 hours postoperatively. Postoperative 
flap monitoring was accomplished by handheld Doppler 
ultrasound and clinical evaluation every hour until 24 
hours after surgery, and thereafter every two hours until 
postoperative day 3 and every 6 hours until discharge. 
Hypotensive episodes were defined as mean arterial pres-
sure less than 65 mm Hg. Relevant surgical and medical 
information was obtained from the patient records.
Primary endpoints were surgical and medical com-
plications (Table  1). Postoperative complications were 
registered during hospital stay and until 2 weeks after 
discharge. Wound infection was diagnosed based on local 
and systemic clinical signs, and/or unexplained rise in 
inflammatory markers (CRP, WBC).
Statistical Analysis
Differences between cohorts were determined using 
chi-Square or Fisher’s exact tests (FET) for binomi-
nal categorical variables and independent sample t-test 
for normally distributed ordinal continuous variables. 
Significantly different variables were included in a mul-
tivariate logistic regression model to assess independent 
association with outcome. Data were analyzed using SPSS 
statistical software (IBM Corp. IBM SPSS Statistics for 
Windows, Version 25.0., Armonk, N.Y.). Statistical signifi-
cance was defined as a P value less than 0.05.
RESULTS
The LFM cohort contained 42 patients, and the MFM 
cohort, 172 patients. There were no significant differ-
ences between cohorts regarding age or body mass index 
(Table  2). Prior radiotherapy was more frequent in the 
MFM cohort (P < 0.05).
Anesthesia and Medical Treatment
The anesthesiologic results are summarized in Tables 3 
and 4. Sevoflurane was the most common anesthetic agent 
in both cohorts. Propofol was much more frequent in the 
MFM cohort, as expected (P < 0.05).
Intraoperatively, the LMF cohort received more 
fluid but had lower urine output. The end-surgery fluid 
accumulation in the LFM cohort was 53.8 ± 22.0 ml/kg 
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Table 2. Patient and Case Characteristics
 
LFM Protocol  
(n = 42)
MFM Protocol  
(n = 172)
Age (y ± SD) 50.6 (± 8.6) 51.3 (± 8.9)
BMI (kg/m2 ± SD) 26.1 (± 3.1) 26.0 (± 2.6)
Prior radiotherapy, n (%) 17 (40.5%) 126 (73.3%)
Prior chemotherapy, n (%) 26 (61.9%) 132 (76.7%)
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compared with 29.6 ± 10.6 ml/kg for the MFM cohort 
(P < 0.05).
In the LFM cohort, 28 patients (66.6%) received col-
loids (Macrodex, Meda AS, Asker, Norway or Voluven, 
Fresenius Kabi Deutschland GmbH, Bad Homburg, 
Germany) compared with eight patients (4.7%) in the 
MFM cohort. While 159 patients (92.5%) in the MFM 
cohort received vasopressors, only one (2.4%) did so 
in the LFM cohort (P < 0.05). Multiple hypotensive epi-
sodes occurred in 13 patients (31%) of the LFM cohort 
compared with eight patients (4.7%) in the MFM cohort 
(P < 0.05).
Preoperative hemoglobin and hematocrit levels 
did not differ significantly between cohorts. The aver-
age intraoperative blood loss was higher in the LFM 
cohort than in the MFM cohort, at 443.8 ± 250.2 ml and 
201 ml ± 124.1 ml, respectively (P < 0.05). Eight patients, 
of which five (11.9%) were in the LFM cohort, needed 
blood transfusion, all postoperatively, mainly because of 
dizziness during mobilization.
Surgical Parameters
Data related to surgical procedures are presented 
in Table  5. The deep inferior epigastric perforator flap 
(DIEP) was the most frequently used flap in both cohorts. 
Contrarily, pedicled transverse rectus abdominis muscu-
locutaneous flaps and free superficial inferior epigastric 
artery flaps comprised over 40% of the flaps in the LFM 
cohort. Procedure time or flap weight did not differ sig-
nificantly. Venous superdrainage was more common in 
the MFM cohort (73.8%) compared with the LFM cohort 
(35.7%) (P < 0.05).
Table 3. Intraoperative Data on Anesthesia and Fluid  
Management






Inhalation agent     
Isoflurane 16 (38.1) 38 (22.1)
 Sevoflurane 25 (59.5) 133 (77.3)
 Other 1 (2.4) 1 (0.6)
Propofol     
 Not used 27 (64.3) 5 (2.9)
 Throughout the procedure 1 (2.4) 45 (26.2)
 Final 2 h 11 (26.2) 100 (58.1)
 Final 3 h    16 (7.5)
 Final 4 h    5 (2.3)
 Single bolus 1 (2.4) 1 (0.6)
 Multiple boluses 2 (3.2)    
Vasopressor agent       
 Not used 41 (97.6) 13 (7.6)
 Norepinephrine    158 (91.9)
 Dopamine 1 (2.4) 1 (0.6)
Colloid type       
 Not used 14 (33.3) 164 (95.3)
 Macrodex 21 (50.0) 8 (4.7)
 Voluven 2 (4.8)    
 Macrodex + Voluven 4 (9.5)    
 Other 1 (2.4)    
Hypotensive episodes     
 None 18 (42.8) 154 (89.5)
 One 11 (26.2) 10 (5.8)
 Several 13 (31.0) 8 (4.7)
Table 4. Intraoperative Fluid Measures and Data on Blood 
Parameters
Measures 
LFM Protocol  
(n = 42)
MFM Protocol  
(n = 172)
Total fluid volume 
(ml ± SD) 4618.3 (± 1857.8) 3141.5 (± 768.3)
Total fluid per weight 
(ml/kg ± SD)




11.0 (± 5.7) 6.8 (± 1.7)
Colloid in treated 
population  
(ml ± SD)




10.2 (± 5.3) 6.5 (± 2.0)
Total urine output 
(UO) (ml ± SD)
769.3 (± 516.6)  1019.0 (± 662.0)
Total UO per weight 
(ml/kg ± SD)
10.5 (± 6.5) 14.3 (± 9.3)
Fluid balance 3849.0 (± 1608.7) 2122.6 (± 791.4)
Fluid balance per 
weight  
(ml/kg ± SD)
53.8 (± 22.0) 29.6 (± 10.6)
Intraoperative blood 
loss (ml ± SD)
















28.7 (± 3.7) 34.4 (± 3.3)
Δ Hemoglobin  
(gr/dl ± SD)
−3.2 (± 1.2) −2.1 (± 1.0)
Δ Hematocrit  
(% ± SD)
−8.1 (± 4.3) −6.1 (± 2.8)
*Missing data from 2/172 (1%) patients in MFM cohort.
†Missing data from 16/42 (38%) in LFM cohort and 20/172 (11%) in MFM 
cohort.
‡Missing data from 7/42 (18%) patients in LFM cohort and 4/172/151 (2%) 
in MFM cohort.
§Missing data from 22/42 (52%) patients in LFM cohort and 10/172 (6%) in 
MFM cohort






Procedure time (min ± SD) 372.1 (± 106.0) 398.2 (± 82.3)
Flap weight (g ± SD) 717.7 (± 220.7) 686.1 (± 180.4)
Flap type, n (%)       
 DIEP 23 (54.8 %) 138 (80.2 %)
 MS-1 TRAM 2 (4.8 %) 25 (14.5 %)
 Pedicled TRAM 13 (31.0 %) 4 (2.3 %)
 SIEA 4 (9.5 %) 5 (2.9 %)
Venous drainage, n (%)       
 DIEV to IMV 27 (64.3 %) 45 (26.2 %)
 Double DIEV to IMV 1 (2.4 %) 30 (17.4 %)
 SIEV to CV 14 (33.3 %) 56 (32.6 %)
 Double DIEV to IMV + SIEV  
 to CV
   18 (10.5 %)
 SIEV to IMV    13 (7.6 %)
 Other    10 (5.8 %)
CV: cephalic vein; DIEV: deep inferior epigastric vein; IMV: internal mammary 
vein; MS-TRAM: muscle sparing transverse rectus abdominalis myocutaneous 
flap; SIEA: superficial inferior epigastric artery perforator flap; SIEV: superfi-
cial inferior epigastric vein. 
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Outcome
Outcome data are presented in Table 6. Intraoperative 
complications were more frequent in the LFM cohort 
compared with those in the MFM cohort, at 28.6% and 
14.5%, respectively (P < 0.05). Intraoperative blood loss 
(>500 ml) was the most frequent complication in the LFM 
cohort and vascular pedicle problems in the MFM cohort.
Postoperatively, surgical and medical complications 
were more frequent in the LFM cohort. The higher inci-
dence of surgical complications, observed in 27 patients 
(42.9%), when compared with in 33 patients (21.9%) in 
the MFM cohort, was mainly related to partial and total 
flap failures (P < 0.05). Postoperative flap complications 
due to vascular insufficiency occurred in 38 patients. 
Emergent exploration was performed in 12 flaps, of which 
three were salvaged. Other postoperative surgical com-
plications were scarce, apart from a significantly higher 
occurrence of postoperative hematoma in the MFM 
cohort [12 patients (7%)], mainly related to the abdomi-
nal donor site. Medical complications, mostly respiratory 
distress, were reported in six patients (14.3%) in the LFM 
cohort and four patients (2.3%) in the MFM cohort (P < 
0.05). Mean length of stay (LOS) was significantly longer 
in the LFM cohort at 12.7 (± 6.5) days compared with 10.5 
(± 2.7) days for the MFM cohort (P < 0.05).
Logistic regression analysis showed a statistically sig-
nificant association between the applied fluid manage-
ment protocol and intraoperative and postoperative 
complications (Table  7). The MFM protocol was more 
beneficial, resulting in reduced odds for complications in 
the range of 57%–85% compared with the LFM protocol. 
Propofol was not independently associated with outcome. 
Likewise, prior radiotherapy, type of inhalation agent, or 
venous superdrainage did not have a statistically signifi-
cant impact on outcome. Post-hoc analysis within the LFM 
cohort found no significant association between flap type 
and the incidence of surgical complications.
Postoperative complications reduced considerably 
after 2003, associated with a concurrent reduction of intra-
operative fluid resuscitation and end-surgery fluid accu-
mulation. The complication rate was further reduced with 
full implementation of the MFM protocol in 2005 (Fig. 1).
DISCUSSION
The MFM protocol resulted in fewer complications for 
unilateral autologous breast reconstructions compared with 
the LFM protocol. Plausible explanations are discussed.
Fluid Resuscitation
Insensible loss and fluid shifting have been the ratio-
nale for large volume resuscitation in the past. Recent 
studies have found these estimations incorrect.12,13 
Intraoperative fluid overload results in tissue edema and 
an increased risk of postoperative complications and pro-
longed recovery.13 Flap-related complications are more 
common when using a LFM.7,8,14,15 Intraoperative crystal-
loid volumes exceeding 7 L, or 130 ml/kg/day have been 
associated with major medical and surgical complica-
tions.7 The ideal intraoperative crystalloid infusion rate is 
reported to be in the range of 3.5–6 ml/kg/h.8
The mean intravenous fluid volume in the LFM cohort 
was 11 ml/kg/h, versus 6.8 ml/kg/h in the MFM cohort 
(Table  4). More noteworthy, as the intraoperative urine 
output was lower in the LFM cohort, the net fluid accu-
mulation at the end of surgery was significantly larger in 
the LFM cohort. We think that fluid accumulation is more 
important that the fluid infusion rate, as the end-surgery 
interstitial edema should be directly correlated to the 
actual fluid uptake. Karamanos et al observed a positive 
impact on outcome with strict fluid management during 
free flap breast reconstructions.15 The fluid accumulation 
in their restricted cohort (4.8 ml/kg/hr) mirrors the find-
ings in our MFM cohort (4.6 ml/kg/h). Furthermore, in 
a goal-directed fluid therapy (GDFT) study on pedicled 
and free flap breast reconstructions, Polanco et al regis-
tered a net fluid accumulation of 317 ml/h for patients 
following an enhanced recovery after surgery (ERAS) pro-
tocol.16 This was almost similar to the end-surgery fluid 
balance in our MFM cohort (325 ml/h). Extracellular 
colloid leakage may contribute to such fluid entrapment 
and prolonged edema.17,18 The more frequent colloid use 
Table 6. Observed Adverse Events and LOS
 
LFM Protocol  
(n = 42)
MFM Protocol  
(n = 172)
Intraoperative complications,  
 n (%)       
 None 30 (71.4%) 147 (85.5%)
 Bleeding (>500 ml) 8 (19.0%) 2 (1.2%)
 Inadequate flow in recipient  
 artery
3 (7.1%) 7 (4.1%)
 Arterial thrombosis    11 (6.4%)
 Venous congestion 1 (2.4%) 1 (0.6%)
 Other    4 (2.3%)
Postoperative surgical  
 complications, n (%)
      
 None 20 (47.6%) 134 (77.9%)
 Bleeding    12 (7.0%)
 Infection 1 (2.4%) 5 (2.9%)
 Wound rupture    4 (2.3%)
 Partial necrosis 14 (33.3%) 11 (6.4%)
 Total flap loss 6 (14.3%) 6 (3.5%)
 Hernia 1 (2.4%)    
Postoperative medical  
 complications, n (%)
      
 None 36 (85.7%) 168 (97.7%)
 Pulmonary embolism 1 (2.4%)    
 Respiratory distress 3 (7.1%) 3 (1.7%)
 Urinary tract infection 1 (2.4%)    
 Other 1 (2.4%) 1 (0.6%)
Length of stay, d (± SD) 12.7 (± 6.5) 10.5 (± 2.7)
Table 7. Regression Analysis of Outcome per Fluid  
Management Protocol
Complications 
 No. Patients (%) 
P
Odds Ratio  
(95% CI)
LFM Protocol 
(n = 42) 
MFM Protocol 
(n = 172)








6 (14.3) 4 (2.3) 0.004 0.143  
(0.038–0.532)
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in the LFM cohort could be a plausible explanation for 
the larger fluid accumulation compared with the MFM 
cohort, although statistical analysis did not find an inde-
pendent association between the use of colloids and out-
come in the present study. Post-hoc analysis showed that 
intra- or postoperative bleeding (>500 ml) was significantly 
more common among patients who had received colloids, 
which are known to alter hemostasis.19 No other adverse 
events associated with colloids were observed.5,20 Others 
reported that colloids are safe to use in flap surgery.14,21,22
Fluid resuscitation using small volumes may be insuffi-
cient to correct hypotension, resulting in an increased risk 
for complications, especially in patients with preoperative 
comorbidities.13,23 An individualized GDFT can therefore 
Fig. 1. Fluid accumulation and flap complications. a, Yearly distribution of mean end-surgery fluid balance in the patient population dur-
ing the study period. a notable reduction is seen after 2002. B, Distribution of the incidence of flap-related complications per year during 
the study period. the incidence of partial flap failure (blue line) is generally higher than the incidence of total flap failure (red line). Flap-
related complications were remarkably fewer after 2002/2003.
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be a beneficial fluid management strategy in autologous 
breast reconstructions.16
Ischemia-reperfusion Injury
IRI in free flap surgery can be a significant risk fac-
tor for adverse events.6 Prolonged duration of ischemia 
is associated with increasing risk of flap loss.24 Propofol 
inhibits platelet aggregation, induces vasodilation, and 
protects against adverse effects of free radicals after flap 
reperfusion.25,26 Propofol was an essential part of the MFM 
protocol and might have had a beneficial impact on the 
outcome, although not detectable on statistical analysis.
Anesthesia
Isoflurane and sevoflurane preserve a high cardiac 
output and adequate microcirculatory flow.27 Sevoflurane 
is particularly beneficial in flap surgery, as it reduces capil-
lary leakage of plasma into the interstitial space and pro-
tects against IRI, thereby limiting tissue edema.28,29 The 
combination of sevoflurane and propofol was essential 
in the MFM protocol. Independent association with out-
come was not observed for either drug, but we believe that 
a synergistic effect of these contributed to the beneficial 
outcomes in the MFM cohort.
Vasoactive Agents
At the time of introduction of our MFM protocol in 
2005, few reports supported the use of vasoactive drugs 
in free flap surgery. Prior animal studies presented con-
tradictory results regarding the impact of vasoconstrictive 
agents on flap perfusion, resulting in a general notion 
that vasopressors could increase the risk of peripheral 
vasospasm, thrombosis, and flap failure.9 Yet, some studies 
reported findings of increased flap perfusion when utiliz-
ing inotropic drugs.30,31 We included norepinephrine in 
the MFM cohort to maintain adequate blood pressure, the 
benefits of which have later been advocated by Eley et al 
in a study comparing the effect of several vasoactive drugs 
on flap perfusion.32
The short half-life of most vasopressors facilitates a 
more precise intraoperative control of the blood pressure, 
which in turn will contribute to reduce the risk of poor 
outcome.2 The higher urine output in the MFM cohort 
can partially be explained by the effect of norepinephrine, 
promoting increased kidney perfusion. Norepinephrine 
also mitigated intravenous fluid resuscitation, as adequate 
blood pressure could be upheld without the need for addi-
tional intravenous fluid. The safety of vasoactive agents in 
reconstructive microsurgery observed in this study falls in 
line with the findings of several recent publications.9,33,34
Postoperative Hemodilution
The impact of reduced oxygen-carrying capacity result-
ing from hemodilution or anemia has been debated. 
Velanovich et al and Mlodinow et al found no associa-
tion between low hematocrit and flap failure.35,36 Others 
have demonstrated a negative effect of a hematocrit level 
at 24%.8,37 Sigurdsson et al recommended a hematocrit 
level at 30%–35% to achieve optimal viscosity and oxygen-
carrying capacity.38 In our study, postoperative hematocrit 
levels were at 31.1% in the LFM cohort and 34.5% in the 
MFM cohort. The difference between pre- and postopera-
tive hematocrit levels was larger in the LFM cohort, which 
can be explained by hemodilution due to higher volumes 
of crystalloid infusion and more frequent use of colloids.
Surgical Factors
Pedicled flaps were more frequent in the LFM cohort. 
Pedicled or free TRAM flaps were chosen when perfora-
tors were insufficient to allow for DIEP breast reconstruc-
tion. Although some reports have found free flaps to be 
an independent risk for ischemic flap complications, oth-
ers have found no such association.39–41 Addressing surgi-
cal site complications specifically, Masoomi et al found no 
correlation with different flap types (free or pedicled).42 
No association between flap type and complications was 
observed on intracohort analysis among patients following 
the LFM protocol. However, the more frequent intraoper-
ative bleeding in the LFM cohort might have been related 
to the more traumatic dissection in pedicled transverse 
rectus abdominis musculocutaneous flaps when com-
pared with the delicate dissection in DIEP flaps.
Insufficient venous drainage is the most frequent cause 
of flap complications.43,44 Venous superdrainage was more 
frequent in the MFM cohort compared with the LFM 
cohort, but venous superdrainage per se did not have an 
independent impact on the postoperative outcome of flap 
complications. In a recent meta-analysis, Lee et al did not 
find sufficient evidence to advocate such procedures in 
autologous breast reconstruction.45 Thus, one could pos-
tulate that an overzealous use of venous super-drainage 
was performed in the present study.
Radiation Therapy
Although prior radiation therapy in breast reconstruc-
tions has been associated with an increased risk of compli-
cations, the present study found no significant impact of 
prior radiotherapy on outcome.46
Length of Stay
Several reports from different surgical disciplines state 
that shorter length of stay (LOS) can be achieved with 
multimodal analgesia, patients of lower American Society 
of Anesthesiologists class, and implementation of ERAS 
protocols. Correspondingly, long-lasting surgery and anes-
thesia as well as excessive fluid administration are known 
to lengthen hospitalization.47,48 A recent publication 
assessing ERAS in free flap breast reconstructions demon-
strated a significantly shorter LOS, with less opioid and 
antiemetic use and with no increase in the rate of major 
complications.49 Polanco et al in their study on ERAS with 
goal-directed fluid therapy also noted a decrease in LOS 
after the implementation of ERAS, but stated that the 
preoperative counseling on shorter hospitalization itself 
might have influenced patients’ expectations in terms of 
LOS.16 Although we did not specifically implement pre-
operative counseling in the MFM protocol, we observed a 
reduced LOS in this patient cohort. Patients in the MFM 
cohort were mobilized earlier, whereas patients in the 
LFM cohort were more frequently hindered by dizziness 
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and peripheral edema. We anticipate that the restric-
tive fluid management was the main factor influencing 
LOS. The geographical nature of our catchment area, 
with many patients traveling long distances to our hospi-
tal, may have mitigated the potential difference in LOS 
between cohorts.
Limitations
The retrospective approach of this study is an obvious 
limitation. The small number of patients, especially in the 
LFM cohort, limits the validity of our findings. The fol-
low-up period of our patients was short. The multimodal 
nature of our modifications to the fluid management pro-
tocol did not allow assessment of the independent impact 
of certain variables, such as colloids or norepinephrine. 
We still postulate that the synergistic effect of these modi-
fications contributed to the improved outcomes in the 
MFM cohort.
An obvious source of bias is the learning curve related 
to complex procedures. This relates to both technical 
details of flap surgery and to a general know-how in the 
surgical and anesthetic team. The higher complication 
rate in the LFM cohort could be partially attributed to 
inexperience. Several studies report a higher incidence 
of adverse events during the first 30 cases.50,51 In contrast, 
Grinsell et al reported that the complication rate did not 
differ between early and late cases and attributed this to 
a more widespread knowledge on flap surgery during 
recent years.52 Even if no significant difference in proce-
dure time between cohorts was observed in the present 
study, the advantage of skilled staff without doubt supports 
successful outcome and might therefore have resulted in 
unjust acclaim for the MFM protocol. Yet, the rather “dra-
matic” improvement in complication rates with the intro-
duction of the MFM protocol seems more likely related 
to the modifications in fluid management than to the 
expected improved prognosis plainly due to increased 
team-competence.
CONCLUSION
Reduced intraoperative fluid resuscitation combined 
with optimized blood pressure control by using norepi-
nephrine and propofol can result in fewer complications 
in unilateral abdominal-flap breast reconstruction.
Professor Louis de Weerd, MD, PhD
Department of Plastic and Reconstructive Surgery
University Hospital of North Norway
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